These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34078439)

  • 1. Expression profiles and prognostic values of BolA family members in ovarian cancer.
    Zhu M; Xiao S
    J Ovarian Res; 2021 Jun; 14(1):75. PubMed ID: 34078439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of Expression and Prognostic Value of Sirtuins in Ovarian Cancer.
    Sun X; Wang S; Li Q
    Front Genet; 2019; 10():879. PubMed ID: 31572453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Values of BolA Family Member Expression in Hepatocellular Carcinoma.
    Wang D; Wang Z; Tao Y
    Biomed Res Int; 2022; 2022():8360481. PubMed ID: 36017386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis.
    Zhang J; Huang S; Quan L; Meng Q; Wang H; Wang J; Chen J
    Biomed Res Int; 2021; 2021():8883800. PubMed ID: 33829065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.
    Xu H; Zou R; Li F; Liu J; Luan N; Wang S; Zhu L
    Cancer Med; 2021 Jun; 10(11):3655-3673. PubMed ID: 33934540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.
    Lei J; He ZY; Wang J; Hu M; Zhou P; Lian CL; Hua L; Wu SG; Zhou J
    Cancer Med; 2021 Apr; 10(8):2924-2939. PubMed ID: 33742531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
    Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
    J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation.
    Li X; Li X; Hu Y; Liu O; Wang Y; Li S; Yang Q; Lin B
    BMC Cancer; 2023 Jun; 23(1):573. PubMed ID: 37349676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
    Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
    J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Expression of
    Zou R; Xu H; Li F; Wang S; Zhu L
    DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis.
    Zuo L; Li X; Tan Y; Zhu H; Xiao M
    J Ovarian Res; 2021 Feb; 14(1):29. PubMed ID: 33563317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
    Wu B; Xi S
    BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of inhibitor of differentiation/DNA-binding gene family in lung cancer using bioinformatics methods.
    Xu S; Wang Y; Li Y; Zhang L; Wang C; Wu X
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32003423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis.
    Feng H; Gu ZY; Li Q; Liu QH; Yang XY; Zhang JJ
    J Ovarian Res; 2019 Apr; 12(1):35. PubMed ID: 31010415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic values of S100 family mRNA expression in ovarian cancer.
    Ma N; Zhu L; Yang L; Cui Y; Zhan Y
    Cancer Biomark; 2019; 25(1):67-78. PubMed ID: 31033462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Values of the Insulin-Like Growth Factor Binding Protein Family in Ovarian Cancer.
    Zheng R; Chen W; Xia W; Zheng J; Zhou Q
    Biomed Res Int; 2020; 2020():7658782. PubMed ID: 33282953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.